Li, Jingxin
Hui, Aimin http://orcid.org/0000-0002-3688-1570
Zhang, Xiang
Yang, Yumei
Tang, Rong
Ye, Huayue
Ji, Ruiru
Lin, Mei
Zhu, Zhongkui
Türeci, Özlem
Lagkadinou, Eleni
Jia, Siyue
Pan, Hongxing
Peng, Fuzhong
Ma, Zhilong
Wu, Zhenggang
Guo, Xiling
Shi, Yunfeng
Muik, Alexander http://orcid.org/0000-0003-4561-2273
Şahin, Uğur
Zhu, Li http://orcid.org/0000-0002-6804-5235
Zhu, Fengcai http://orcid.org/0000-0002-1644-0006
Article History
Received: 28 December 2020
Accepted: 23 March 2021
First Online: 22 April 2021
Competing interests
: A.H., Y.Y. and R.J. are employees of Fosun Pharma and may hold stock options. U.Ş. and Ö.T. are stock owners, management board members and employees at BioNTech SE (Mainz, Germany), and are inventors on patents and patent applications related to RNA technology. E.L. and A.M. are employees at BioNTech SE (Mainz, Germany). All other authors have no competing interests.
Free to read: This content has been made available to all.